Schweiter Technologies AG (0QR1)
London Exchange · UK · prices in GBP · close of 23 Oct 2026
Key indicators
| Last close | GBP 343.50 |
|---|---|
| 52-week range | 235.49 – 369.00 |
| Return, 1 month / 3 months | −6.4% / +13.2% |
| Return, 1 year / 3 years | +24.2% / −32.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 35 |
| Volatility (1 year) | 35.0% |
| Worst drawdown (1 year) | -18.9% |
| Average daily value traded | 0.09M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Schweiter Technologies is a Swiss industrial group based in Horgen. Through its Satisloh business it supplies machines and systems used to produce and finish optical lenses, serving eyewear laboratories and lens manufacturers. Its composites arm makes lightweight panels, sheets and components from materials such as aluminium and plastic for construction, display and transport applications. Customers are industrial firms and trade processors in Europe and other markets.
Schweiter Technologies AG trades under the code 0QR1 on the London Exchange in UK, with its price quoted in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Schweiter Technologies AG (0QR1) trades on the London Exchange in UK. It last closed at GBP 343.50 on 23 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 635 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 24.2% and over the last three months it rose 13.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 84 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.6% | ||
| From 52-week high | -6.7% | ||
| Momentum | 82 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 13.2% | ||
| 6-month return | 26.8% | ||
| 12-month return, skipping the last month | 32.7% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.9% | ||
| Liquidity | 30 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.09M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −6.7% |
|---|---|
| 1 month | −6.4% |
| 3 months | +13.2% |
| 6 months | +26.8% |
| 1 year | +24.2% |
| 3 years | −32.2% |
| 5 years | −74.5% |
Signals
| 50-day / 200-day average | 357.45 / 302.44 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.99 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Apr 2026 | GBX 0.1500 |
| 11 Apr 2025 | GBX 0.1500 |
| 12 Apr 2024 | GBX 0.1500 |
| 6 Apr 2023 | GBX 0.2000 |
| 8 Apr 2022 | GBX 0.4000 |
| 7 Apr 2021 | GBX 0.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.